SpaceX IPO Surges 22%, But Analysts Flag Overvaluation Risk
SpaceX debuted above $170 after a $135 IPO price, yet Morningstar pegs fair value at $63, citing key risks ahead.
SpaceX made a dramatic entrance into public markets, with its shares climbing more than 22% on debut day to trade above $170 — well beyond the $135 IPO price that already made this the largest stock offering in history. The enthusiasm reflects years of pent-up demand from retail investors who had no way to access one of the most closely watched private companies in the world. But a strong opening pop and a sound long-term investment thesis are not the same thing.
Morningstar analysts are striking a notably cautious tone, placing their fair value estimate at just $63 per share — a figure that implies the market is pricing in an extraordinarily optimistic future that may not materialize on the timeline investors expect. That gap between the trading price and the analyst estimate is not a minor disagreement; it represents a fundamental divergence over how quickly SpaceX can convert its technological ambitions into durable, scalable earnings.
Read more Church & Dwight Stock Sits Quiet With No Fresh Catalysts →
Two near-term catalysts will test investor conviction almost immediately. The company's first earnings report as a public entity will force a level of financial transparency that private-market shareholders never demanded, and any shortfall in Starlink subscriber growth or unexpectedly heavy Starship R&D expenditures could quickly puncture the post-IPO euphoria. Markets are notoriously unforgiving when a high-multiple stock fails to deliver on its implied growth story in the early quarters after listing.
Perhaps the more structural concern is the looming supply of shares from pre-IPO investors. As lockup periods expire this summer, early backers who entered at far lower valuations will have both the incentive and the legal ability to sell, potentially flooding the market with new supply at a moment when retail enthusiasm may be cooling. This dilution dynamic is a familiar chapter in the post-IPO playbook — and one that has humbled plenty of celebrated debuts before SpaceX.
For investors considering a position, the core question is whether Starlink's subscription trajectory and the long-term commercial potential of Starship justify a valuation that already prices in near-flawless execution. Morningstar's analysts suggest it does not, at least not yet. Continue reading at Morningstar.
